🔗 Share this article

Acclaimed R&B singer D’Angelo passed away on October 14 at 51 years old after a private battle with pancreatic malignancy.

“The brilliant light of our family has dimmed his light for us in the present world,” his family confirmed. “After a lengthy and brave battle with the disease, we are deeply saddened to announce that D’Angelo, known to his fans around the world as D’Angelo, has been taken from us.”

D’Angelo left an indelible mark on the music industry with his pioneering neo-soul sound and collaborations with high-profile artists.

He released his first record, “Brown Sugar,” in 1995 to instant praise. The album achieved No. 4 on the R&B charts, went platinum later that year, and earned multiple Grammy nominations.

However, it was his second album, “Voodoo,” in the year 2000 that propelled his music career into the stratosphere. The record debuted at the top spot on each of Billboard’s Top R&B Albums chart and the Billboard 200. He won two Grammy Awards: Best R&B Album and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” cemented D’Angelo’s standing as a sex symbol, albeit a reluctant one, in the public consciousness. The intimate portrayal showed the singer, famously bare to his midsection, performing straight into the camera.

D’Angelo stepped back from the public eye after releasing Voodoo and openly battled with substance abuse. In 2005, he was part of a serious vehicle accident that put him in critical condition.

Over ten years later, his third and final album, “Black Messiah” (2014), confirmed his enduring appeal with another top chart entry on the R&B chart and a Grammy for Best R&B Album.

Once more, in his own mysterious fashion, D’Angelo made only a few public appearances in the following years.

The singer was announced as a top act for the 2025 music event, but his appearance was called off, due to an “unforeseen medical delay.”

Although information is limited about D’Angelo’s health in the months before his death, he had apparently been in the hospital for an extended period and in hospice for two weeks.

D’Angelo’s demise is a clear example of the harmful impact of pancreatic malignancy, one of the most deadly and hardest to prevent types of the illness, on a gifted artist whose life was ended too soon.

“We are grieved that he can only leave cherished moments with his loved ones, but we are forever thankful for the legacy of extraordinarily moving music he has left us,” his kin said.

Pancreatic Malignancy: Lethal and Rarely Preventable

Pancreatic malignancy impacts the pancreas, a small organ that produces the hormone insulin and plays an essential role in digestion, among other functions. The position and dimensions of the pancreas in the human system make it more challenging to identify malignancy.

Although pancreatic cancer accounts for only about 3% of malignancy cases each year in the U.S., it is responsible for 7% of malignancy fatalities.

Almost seventy thousand individuals will be found to have pancreatic cancer and about fifty-two thousand will die of the disease in 2025.

“This malignancy is one of the deadliest cancers, with an aggressive tumor and dismal outcomes. We have few and poor treatment options, and a narrow opportunity to make a significant difference on the well-being of people,” said a medical oncologist.

Since this disease rarely causes early symptoms, it’s often identified only once the condition is advanced. Even when a individual has indicators they are often nonspecific and may be mistaken for a several everyday ailments.

“Currently, there is no good way to identify pancreatic cancer in the initial phases, apart from listening to your body and consulting your doctor if there are new or unusual signs,” explained a health expert.

Frequent indicators of pancreatic cancer include:

• discomfort in the stomach or back
• weight loss
• yellowing of skin and eyes
• loss of appetite
• dark urine
• light-colored or greasy stools
• loose stools
• increased appetite or thirst
• feeling sick

At age 51, D’Angelo’s demise is an outlier, as pancreatic cancer is most common in adults in the 65 to 75 range. However, numerous malignancies, such as pancreatic cancer, have become more common in younger people.

“This disease diagnosed prior to fifty is considered uncommon, yet concerningly, clinicians are beginning to see a growing number of younger patients suffering from this disease,” commented a specialist.

Genetic Background Affects Cancer Risk

In the absence of reliable screening tools for pancreatic cancer, professionals stressed the importance of knowing your relatives’ cancer history. Certain risk factors, such as tobacco use and excess weight also play a role in the development of this disease.

African Americans have the highest incidence of this malignancy in the U.S. and are more prone to be found to have inoperable cancer.

“The first step toward lowering one’s risk of this condition is understanding personal risk factors. People should review their genetic background, hereditary factors, and medical conditions, such as blood sugar disease, chronic pancreatitis, or obesity that may increase their susceptibility,” said a medical professional.

Hereditary risk factors are associated with as much as ten percent of all pancreatic cancer instances. If a relative in your household has had this disease, you may want to consider DNA analysis.

“For people with a family history of pancreatic cancer or those carrying elevated risk genetic mutations, checking may involve sophisticated scans such as magnetic resonance imaging (MRI) or endoscopic ultrasound (EUS) to find early changes in the organ,” he clarified.

For those looking to lower their chance, habit adjustments may make a difference. The best action you can take to reduce your susceptibility of pancreatic cancer is to quit smoking, and if you don’t smoke, avoid exposure altogether.

Excessive drinking is associated with pancreas inflammation, a risk factor for pancreatic cancer, so reducing or avoiding drinks may help lower your chance.

Managing your weight or shedding pounds may also help decrease your susceptibility. Individuals with obesity are twenty percent more prone to get this disease. Pancreatic cancer also is more frequent in those with diabetes, and reducing weight can also lower the risk of adult-onset diabetes.

Despite pancreatic cancer’s grim outlook, there is reason for optimism.

“We are doing better with treatments and newer combination chemotherapy. There are developing targeted therapies that are already showing results,” remarked a expert.

For many people, however, education about this rare but {dev